<DOC>
	<DOCNO>NCT02567084</DOCNO>
	<brief_summary>The purpose study assess ability injectable bi-phasic ceramic bone substitute provide bone generation bone remodel patient benign bone tumor .</brief_summary>
	<brief_title>Complete Twelve Month Bone Remodeling With Bi-phasic Injectable Bone Substitute Benign Bone Tumors</brief_title>
	<detailed_description>The aim study ass usefulness injectable bi-phasic ceramic bone substitute ( CERAMENT™ |BONE VOID FILLER ) patient benign bone tumor . The primary objective : 1 . Assess ability bi-phasic ceramic bone substitute provide bone generation bone remodel patient benign bone tumor . 2 . Assess safety bi-phasic ceramic bone substitute measure device complaint/Adverse Events monitor documentation subsequent surgical procedure . 3 . In case bone cysts assess ability bi-phasic ceramic bone substitute transform bone possibly induce bone formation region cyst filled product . Benign bone tumor often treat intralesional curettage create bone defect fill e.g . demineralize bone matrix , autologous bone , ceramic bone substitute polymethylmetacrylate cement . Autograft consider golden standard posse three essential element require optimal bone graft , associate morbidity donor site limit supply . Allograft employ good alternative autograft concern potential disease transmission remain . Synthetic bone graft substitute gain popularity viable alternative void defect fill eliminate concern autograft allograft . These synthetic bone substitute invariably base calcium phosphate and/or calcium sulfate material osteoconductive facilitate bone remodel , although side effect drainage wind complication slow remodel bone negligible bone generation limit use . Thus , new synthetic bone substitute describe positive effect vertebroplasty , osteotomy , small trauma defect merit investigation also treatment large bone defect . In prospective series , patient benign bone tumor treat minimal invasive intervention bi-phasic injectable ceramic bone substitute ( CERAMENT™ BONE VOID FILLER ) , compose 60 % weight synthetic calcium sulfate ( CaS ) 40 % weight hydroxyapatite ( HA ) powder mixed water-soluble radio-contrast agent iohexol ( 180 mg/ml ) make material radiopaque . The defect treat either mini-invasive surgery ( solid tumor ) percutaneous injection ( cyst ) follow clinically radiologically 12 month . CT scan perform 12 month confirm bone remodel bone substitute . All patient allow full weight bear immediately surgery .</detailed_description>
	<mesh_term>Bone Cysts</mesh_term>
	<criteria>Patients admit hospital surgical treatment benign bone lesion require bone grafting . Patient 6 year ageIrreversible coagulopathy bleed disorder . Note regard reversible coagulopathies : Patients coumarin anticoagulant may participate . Investigators follow routine practice perioperative discontinuation reinitiation anticoagulant ; A preexist calcium metabolism disorder ( e.g . hypercalcemia ) .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Bone substitute</keyword>
	<keyword>benign bone cyst</keyword>
	<keyword>ceramic</keyword>
	<keyword>remodelling</keyword>
</DOC>